Afatinib Expanded Access Program

Clinical trial NCT01649284 · APPROVED_FOR_MARKETING

Trial details

NCT number: NCT01649284
Sponsor: Boehringer Ingelheim
Status: APPROVED_FOR_MARKETING
Study type: EXPANDED_ACCESS

Carcinoma, Non-Small-Cell Lung

Start date: 2012-07-01
Primary completion: 2014-03-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.